IDL Biotech AB launched TUBEX TF, a rapid test for typhoid fever in Kenya. Launch took place at Kenya Medical Research Institute in the presence of doctors, pathologists, and representatives from the Ministry of Health.
BD launched a new automated cytometry system. The system enhances efficiency by reducing the chances of errors and reducing human intervention
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 4164
Published Date: Aug 10, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Typhoid is on the rise in developing countries and increased competition among top competitors to produce fast and cost-effective diagnostic kits to diagnose typhoid cases is anticipated to boost the market growth.
The market is anticipated to attain a CAGR of 7% over the forecast period i.e., 2023 â€“ 2035.
The market in Asia Pacific is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
The major players in the market are LINEAR CHEMICALS, S.L.U, Medical Innovation Ventures Sdn Bhd, Thermo Fisher Scientific, Nuclear Lifesciences Ltd., DIALAB GmbH., BIOSYSTEMS S.A., and others.
The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.